Safety data sheet

SIGMA-ALDRICH
sigma-aldrich.com
Material Safety Data Sheet

1. PRODUCT AND COMPANY IDENTIFICATION
3050 Spruce Street SAINT LOUIS MO 63103 USA both supplier and manufacturer) Preparation Information Product Safety - Americas Region 1-800-521-8956
2. HAZARDS IDENTIFICATION
Emergency Overview
OSHA Hazards
Target Organ Effect, Harmful by ingestion., Irritant
Target Organs
GHS Classification
Acute toxicity, Oral (Category 4)
Skin irritation (Category 2)
Eye irritation (Category 2A)
Specific target organ toxicity - single exposure (Category 3)
GHS Label elements, including precautionary statements
Avoid breathing dust/ fume/ gas/ mist/ vapours/ spray. Do not eat, drink or smoke when using this product. Use only outdoors or in a well-ventilated area. Wear protective gloves/ eye protection/ face protection. IF SWALLOWED: Call a POISON CENTER or doctor/ physician if you feel unwell. IF ON SKIN: Wash with plenty of soap and water. IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for Sigma - D9628
IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. Call a POISON CENTER or doctor/ physician if you feel unwell. Specific treatment (see supplemental first aid instructions on this label). If skin irritation occurs: Get medical advice/ attention. If eye irritation persists: Get medical advice/ attention. Take off contaminated clothing and wash before reuse. Store in a well-ventilated place. Keep container tightly closed. Dispose of contents/ container to an approved waste disposal plant. HMIS Classification
Health hazard:
Chronic Health Hazard:
Flammability:
Physical hazards:
NFPA Rating
Health hazard:
Reactivity Hazard:
Potential Health Effects
Inhalation
May be harmful if inhaled. Causes respiratory tract irritation. Harmful if absorbed through skin. Causes skin irritation. Ingestion

3. COMPOSITION/INFORMATION ON INGREDIENTS
Levodopa 3-(3,4-Dihydroxyphenyl)-L-alanine L-DOPA Levodopa
59-92-7

4. FIRST AID MEASURES
General advice
Consult a physician. Show this safety data sheet to the doctor in attendance.Move out of dangerous area.
If inhaled
If breathed in, move person into fresh air. If not breathing, give artificial respiration. Consult a physician.
In case of skin contact
Wash off with soap and plenty of water. Consult a physician.
In case of eye contact
Rinse thoroughly with plenty of water for at least 15 minutes and consult a physician.
If swallowed
Never give anything by mouth to an unconscious person. Rinse mouth with water. Consult a physician.
Sigma - D9628

5. FIRE-FIGHTING MEASURES
Suitable extinguishing media
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.
Special protective equipment for fire-fighters
Wear self contained breathing apparatus for fire fighting if necessary.
Hazardous combustion products
Hazardous decomposition products formed under fire conditions. - Carbon oxides, nitrogen oxides (NOx)

6. ACCIDENTAL RELEASE MEASURES
Personal precautions
Use personal protective equipment. Avoid dust formation. Avoid breathing vapors, mist or gas. Ensure adequate
ventilation. Evacuate personnel to safe areas. Avoid breathing dust.
Environmental precautions
Do not let product enter drains.
Methods and materials for containment and cleaning up
Pick up and arrange disposal without creating dust. Sweep up and shovel. Keep in suitable, closed containers for
disposal.

7. HANDLING AND STORAGE
Precautions for safe handling
Avoid contact with skin and eyes. Avoid formation of dust and aerosols.
Provide appropriate exhaust ventilation at places where dust is formed. Normal measures for preventive fire protection.
Conditions for safe storage
Keep container tightly closed in a dry and well-ventilated place.

8. EXPOSURE CONTROLS/PERSONAL PROTECTION
Contains no substances with occupational exposure limit values. Personal protective equipment
Respiratory protection
For nuisance exposures use type P95 (US) or type P1 (EU EN 143) particle respirator.For higher level protection
use type OV/AG/P99 (US) or type ABEK-P2 (EU EN 143) respirator cartridges. Use respirators and components
tested and approved under appropriate government standards such as NIOSH (US) or CEN (EU).
Hand protection
Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique (without touching
glove's outer surface) to avoid skin contact with this product. Dispose of contaminated gloves after use in
accordance with applicable laws and good laboratory practices. Wash and dry hands.
Eye protection
Safety glasses with side-shields conforming to EN166 Use equipment for eye protection tested and approved under
appropriate government standards such as NIOSH (US) or EN 166(EU).
Skin and body protection
Complete suit protecting against chemicals, The type of protective equipment must be selected according to the
concentration and amount of the dangerous substance at the specific workplace.
Hygiene measures
Handle in accordance with good industrial hygiene and safety practice. Wash hands before breaks and at the end of
workday.
Sigma - D9628
9. PHYSICAL AND CHEMICAL PROPERTIES
Appearance
Safety data
Melting point/range: 276 - 278 °C (529 - 532 °F) - lit.
10. STABILITY AND REACTIVITY
Chemical stability
Stable under recommended storage conditions.
Possibility of hazardous reactions
no data available
Conditions to avoid
Air Light.
Materials to avoid
Strong oxidizing agents
Hazardous decomposition products
Hazardous decomposition products formed under fire conditions. - Carbon oxides, nitrogen oxides (NOx)
Other decomposition products - no data available

11. TOXICOLOGICAL INFORMATION
Acute toxicity
Oral LD50
LD50 Oral - rat - 1,780 mg/kg
Remarks: Behavioral:Excitement. Behavioral:Ataxia. Behavioral:Aggression.
Inhalation LC50
Dermal LD50
no data available
Sigma - D9628
Other information on acute toxicity
no data available
Skin corrosion/irritation
no data available
Serious eye damage/eye irritation
no data available
Respiratory or skin sensitization
no data available
Germ cell mutagenicity
no data available
Carcinogenicity
No component of this product present at levels greater than or equal to 0.1% is identified as probable, possible or confirmed human carcinogen by IARC. No component of this product present at levels greater than or equal to 0.1% is identified as a carcinogen or potential carcinogen by ACGIH. No component of this product present at levels greater than or equal to 0.1% is identified as a known or anticipated carcinogen by NTP. No component of this product present at levels greater than or equal to 0.1% is identified as a carcinogen or potential carcinogen by OSHA. Reproductive toxicity
Teratogenicity
Specific target organ toxicity - single exposure (Globally Harmonized System)
Inhalation - May cause respiratory irritation.
Specific target organ toxicity - repeated exposure (Globally Harmonized System)
no data available
Aspiration hazard
no data available
Potential health effects
Inhalation
May be harmful if inhaled. Causes respiratory tract irritation. Ingestion
Harmful if absorbed through skin. Causes skin irritation. Signs and Symptoms of Exposure
Nausea, Headache, Vomiting
Synergistic effects
no data available
Additional Information
RTECS: AY5600000

12. ECOLOGICAL INFORMATION
Toxicity
Persistence and degradability
Sigma - D9628
Bioaccumulative potential
no data available
Mobility in soil
no data available
PBT and vPvB assessment
no data available
Other adverse effects

13. DISPOSAL CONSIDERATIONS
Product
Offer surplus and non-recyclable solutions to a licensed disposal company. Contact a licensed professional waste
disposal service to dispose of this material.
Contaminated packaging
Dispose of as unused product.

14. TRANSPORT INFORMATION
DOT (US)
Not dangerous goods
IMDG
Not dangerous goods
IATA
Not dangerous goods

15. REGULATORY INFORMATION
OSHA Hazards
Target Organ Effect, Harmful by ingestion., Irritant
SARA 302 Components
SARA 302: No chemicals in this material are subject to the reporting requirements of SARA Title III, Section 302.
SARA 313 Components
SARA 313: This material does not contain any chemical components with known CAS numbers that exceed the threshold
(De Minimis) reporting levels established by SARA Title III, Section 313.
SARA 311/312 Hazards
Acute Health Hazard, Chronic Health Hazard
Massachusetts Right To Know Components
No components are subject to the Massachusetts Right to Know Act.
Pennsylvania Right To Know Components
New Jersey Right To Know Components
California Prop. 65 Components
WARNING! This product contains a chemical known to the State of California to cause birth defects or other reproductive harm.
16. OTHER INFORMATION
Sigma - D9628
Further information
Copyright 2011 Sigma-Aldrich Co. License granted to make unlimited paper copies for internal use only.
The above information is believed to be correct but does not purport to be all inclusive and shall be used only as a
guide. The information in this document is based on the present state of our knowledge and is applicable to the
product with regard to appropriate safety precautions. It does not represent any guarantee of the properties of the
product. Sigma-Aldrich Co., shall not be held liable for any damage resulting from handling or from contact with the
above product. See reverse side of invoice or packing slip for additional terms and conditions of sale.
Sigma - D9628

Source: http://www2.uttyler.edu/biology/faculty/bextine/bextine_lab/bextine_lab_documents/msds%203%204%20dihydroxy%20l%20phenylalanine.pdf

Infectious complications of dialysis access devices

KEYWORDS Dialysis  Device infection  Renal diseaseDuring the past 2 decades, the incidence of end-stage renal disease (ESRD) in theUnited States has more than doubled, with more than 380,000 patients currentlyreceiving maintenance dialysis.During this same time period, significant advanceshave been made in dialysis care and overall However, dialysis access canbe problematic, including vascular

How to look after someone with h1n1 flu virus

LOOKING AFTER SOMEONE AT HOME WITH H1N1 FLU VIRUS Note: This guidance document is being provided by the Public Health Agency of Canada in response to the recent outbreak of H1N1 flu virus (human swine flu) in Canada. This guidance has been developed to assist people in caring for someone at home who is recuperating from the virus. This guidance is based on current available scientific evid

Copyright © 2008-2018 All About Drugs